These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. Hemodynamic effects of inducible nitric oxide synthase inhibition combined with sildenafil during acute pulmonary embolism. Dias-Junior CA; Neto-Neves EM; Montenegro MF; Tanus-Santos JE Nitric Oxide; 2010 Dec; 23(4):284-8. PubMed ID: 20804854 [TBL] [Abstract][Full Text] [Related]
7. Hemodynamic effects of sildenafil interaction with a nitric oxide donor compound in a dog model of acute pulmonary embolism. Dias-Junior CA; Tanus-Santos JE Life Sci; 2006 Jun; 79(5):469-74. PubMed ID: 16504213 [TBL] [Abstract][Full Text] [Related]
8. A role for matrix metalloproteinase-9 in the hemodynamic changes following acute pulmonary embolism. Fortuna GM; Figueiredo-Lopes L; Dias-Junior CA; Gerlach RF; Tanus-Santos JE Int J Cardiol; 2007 Jan; 114(1):22-7. PubMed ID: 16650492 [TBL] [Abstract][Full Text] [Related]
9. Protective effects of atorvastatin in rat models of acute pulmonary embolism: involvement of matrix metalloproteinase-9. Souza-Costa DC; Figueiredo-Lopes L; Alves-Filho JC; Semprini MC; Gerlach RF; Cunha FQ; Tanus-Santos JE Crit Care Med; 2007 Jan; 35(1):239-45. PubMed ID: 17133179 [TBL] [Abstract][Full Text] [Related]
10. Sildenafil improves the beneficial hemodynamic effects exerted by atorvastatin during acute pulmonary thromboembolism. Neto-Neves EM; Dias-Junior CA; Uzuelli JA; Pereira RP; Spiller F; Czaikoski PG; Tanus-Santos JE Eur J Pharmacol; 2011 Nov; 670(2-3):554-60. PubMed ID: 21946107 [TBL] [Abstract][Full Text] [Related]
11. Effects of phosphodiesterase 5 inhibitor on pulmonary vascular reactivity in the fetal lamb. Jaillard S; Larrue B; Deruelle P; Delelis A; Rakza T; Butrous G; Storme L Ann Thorac Surg; 2006 Mar; 81(3):935-42. PubMed ID: 16488698 [TBL] [Abstract][Full Text] [Related]
13. Chronic inhibition of phosphodiesterase 5 does not prevent pressure-overload-induced right-ventricular remodelling. Schäfer S; Ellinghaus P; Janssen W; Kramer F; Lustig K; Milting H; Kast R; Klein M Cardiovasc Res; 2009 Apr; 82(1):30-9. PubMed ID: 19131365 [TBL] [Abstract][Full Text] [Related]
14. Sildenafil prevents cardiovascular changes after bone marrow fat embolization in sheep. Krebs J; Ferguson SJ; Nuss K; Leskosek B; Hoerstrup SP; Goss BG; Aebli N Anesthesiology; 2007 Jul; 107(1):75-81. PubMed ID: 17585218 [TBL] [Abstract][Full Text] [Related]
15. Systemic and splanchnic haemodynamic effects of sildenafil in an in vivo animal model of cirrhosis support for a risk in cirrhotic patients. Colle I; De Vriese AS; Van Vlierberghe H; Lameire NH; DeVos M Liver Int; 2004 Feb; 24(1):63-8. PubMed ID: 15102002 [TBL] [Abstract][Full Text] [Related]
16. Effects of sildenafil on pulmonary hypertension and levels of ET-1, eNOS, and cGMP in aorta-banded rats. Dai ZK; Tan MS; Chai CY; Chou SH; Lin PC; Yeh JL; Jeng AY; Chang CI; Chen IJ; Wu JR Exp Biol Med (Maywood); 2006 Jun; 231(6):942-7. PubMed ID: 16741028 [TBL] [Abstract][Full Text] [Related]
17. Acute hemodynamic effects of intravenous sildenafil citrate in congestive heart failure: comparison of phosphodiesterase type-3 and -5 inhibition. Botha P; Parry G; Dark JH; Macgowan GA J Heart Lung Transplant; 2009 Jul; 28(7):676-82. PubMed ID: 19560695 [TBL] [Abstract][Full Text] [Related]
18. Effect of oral sildenafil citrate on intraoperative hemodynamics in patients with pulmonary hypertension undergoing valvular heart surgery. Shim JK; Choi YS; Oh YJ; Kim DH; Hong YW; Kwak YL J Thorac Cardiovasc Surg; 2006 Dec; 132(6):1420-5. PubMed ID: 17140970 [TBL] [Abstract][Full Text] [Related]
19. Ranolazine, a novel anti-anginal agent, does not alter isosorbide dinitrate- or sildenafil-induced changes in blood pressure in conscious dogs. Zhao G; Messina E; Xu X; Ochoa M; Serpillon S; Shryock J; Belardinelli L; Hintze TH Eur J Pharmacol; 2006 Jul; 541(3):171-6. PubMed ID: 16777088 [TBL] [Abstract][Full Text] [Related]
20. Effect of sildenafil on pulmonary artery pressure, systemic pressure, and nitric oxide utilization in patients with left ventricular assist devices. Klodell CT; Morey TE; Lobato EB; Aranda JM; Staples ED; Schofield RS; Hess PJ; Martin TD; Beaver TM Ann Thorac Surg; 2007 Jan; 83(1):68-71; discussion 71. PubMed ID: 17184632 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]